TwoFour Insight (@TwoFourInsight) header
TwoFour Insight (@TwoFourInsight) profile picture

Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets ≠ endorsement

Pitt | WashDC | New Delhi
Joined January 2014
Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)Photo by TwoFour Insight (@TwoFourInsight)
TwoFour Insight retweeted
CHAT WITH @BiovoiceNews features Ms Abby Prat of @AdvaMedUpdate Read what #MedTech MNCs think of regulatory revamp. biovoicenews.com/largest-cha…
2
1
TwoFour Insight retweeted
US FDA unveils long-awaited biosimilar guidance biopharma-reporter.com/Marke… @ASHPOfficial @VizientInc – at Irving, TX
1
1
TwoFour Insight retweeted
#Lupin ’s tussle with the #FDA and Investors – a lesson for the #Pharma #Nifty #Sensex #India capitalmind.in/2016/03/lupin…
1
1
TwoFour Insight retweeted
Celebrating the Global Impact of Quality: USP-#India’s 10th Anniversary and Beyond | Quality Matters - https://teapawt.net/t.co/WIPL1UYAdM
Here's how #India can fight rising #antibiotic resistance #healthcare #pharma @DrFriedenCDC @HospitalsApollo https://teapawt.net/t.co/x7X0XUeVbj
TwoFour Insight retweeted
Replying to @TwoFourInsight
@TwoFourInsight @NiveditaSaksena India has always had support from IPA and academics like Srividhya Ragavan & Brook Baker
TwoFour Insight retweeted
Mylan India manufacturing falls short, leaving Sandoz to recall 277,000 bottles of blood pressure med. fiercepharmamanufacturing.co… #pharma
' #DigitalIndia 'Will Transform the #Country , Says @rsprasad https://teapawt.net/t.co/gRFOAbWJzg #digitalmatters #digitalhealth @TwoFourInsight
2
1
Tenure of DBT Secretary @kvijayraghavan extended by 2 yrs, strengthens department's resolve to work for excellence ptinews.com/news/7121344_Tri… – at Noida, India
1
14
10
TwoFour Insight retweeted
Such a pity! You'd think this was a given for firms that notch up ~50% of revenue from the US.Better late than never teapawt.net/VikasDandekarET/status…
Finding cure to a chronic malady...Indian drug makers team up for quality at manufacturing sites economictimes.indiatimes.com…
1
1
1
TwoFour Insight retweeted
#India #pharma #regulation #drugs Akun said he prefers sending his regulators to US FDA for training because of this teapawt.net/dineshcsharma/status/6…
India has no training center for its drug regulators: Akun Sabharwal, drug controller at @RIS_NewDelhi meeting on SDGs @Sachin_Chat
#TPP on @Medium: Message from @POTUS ✓ Full text of the agreement ✓ Summaries of every chapter ✓ Check it out → go.wh.gov/TPPText
27
146
2
95
RT @OrinLevine: Great to see Gavi announcement to purchase #Ebola vaccine & create 300K dose global stockpile ow.ly/XlTX1 #WEF16
6
1
TwoFour Insight retweeted
.@CCI_India approves acquisition of certain brands of Johnson and Johnson by Strides Shasun Limited”
TwoFour Insight retweeted
India’s #biotech advisory committee to meet tomorrow to discuss GM mustard - The Economic Times economictimes.indiatimes.com…
TwoFour Insight retweeted
Express Scripts rolls out value-based pricing for cancer meds https://teapawt.net/t.co/BVdXBERZfX #pharma
#HRNewsIndia Competition Commission of India received record 127 M&A cases in 2015: The Competition Commission, in… dlvr.it/D8q9bC
TwoFour Insight retweeted
It's official: @POTUS will participate in @hannover_messe USA Partner Country 2016! #HM16USA
18
14
TwoFour Insight retweeted
Indias pharma industry may touch $55 bn by 2020: Report t.in.com/bY7i
4
2
TwoFour Insight retweeted
Is India battling an incurable #healthcare crisis? | @SaifAKhan | https://teapawt.net/t.co/b5X1YbkhmW
1
18
16